Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.2 USD | +3.11% | +0.19% | +39.84% |
01:31pm | Leerink Partners Starts XOMA With Outperform Rating, $40 Price Target | MT |
03/04 | XOMA Corporation completed the acquisition of Kinnate Biopharma Inc.. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.84% | 296M | |
-2.62% | 103B | |
+1.53% | 95.28B | |
+1.46% | 22.15B | |
-15.87% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.02% | 16.05B | |
+5.16% | 13.68B | |
+33.86% | 12.17B |
- Stock Market
- Equities
- XOMA Stock
- News XOMA Corporation
- Insider Trends: Xoma Insider Gets Stock Award, Buy Trend Intact